mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
VL

Valiant Laboratories Limited

NSE:VALIANTLABBSE:VALIANTLAB
HealthcarePharmaceuticals & Biotechnology
₹125.1
-0.91%1 Oct close
Mkt cap
₹679 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
AnnualQuarterly
ConsolidatedStandalone

Consolidated figures · ₹ crore

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
334182133237
COGS277168117197
Gross profit57141740
23222134
34-8-56
OPM %10%-4.6%-3.5%2.7%
Depreciation—226
Interest0002
51052
Profit before tax38-1-21
Tax9-114
Tax %24%-141.6%45.7%524.7%
290-2-3
PAT margin %8.7%0.2%-1.7%-1.4%
EPS (₹)8.90.1-0.5-0.5
EPS adjusted (₹)8.90.1-0.5-0.6
Annual report—Annual report for Mar 2024Annual report for Mar 2025—

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
Equity capital33434354
Reserves68193191257
Minority interest———0
597612145
533045108
Total equity & liabilities213343401464
475048227
CWIP1431566
Investments3438026
131212197205
Total assets213343401464

₹ CrMar 2023Mar 2024Mar 2025Mar 2026
5621-10
-55-144-537
-1152452
Net cash flow-010-7-1
Free cash flow18-44-113-45
CFO / Operating profit %167.2%——-163.2%

Compounded sales growth

7 years
—
5 years
—
3 years
-11%
1 year
78%

Stock price CAGR

10 years
—
5 years
—
3 years
—
1 year
47%

Return on equity

7 years
—
5 years
—
3 years
-1%
Last year
-1%